Investors

INMODE INVESTOR PORTAL

CORPORATE OVERVIEW


InMode Ltd. (Nasdaq: INMD) is a leading global provider of innovative medical technologies. InMode develops, manufacturers, and markets devices harnessing novel radio-frequency (RF) based devices that strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology and ophthalmology.

COMPANY HIGHLIGHTS

STOCK PERFORMANCE

NASDAQ : INMD

PRICE

$0

CHANGE

0(0%)

VOLUME

0

Copyright Nasdaq. Latest trading day: .

Press Releases

InMode to Present at Upcoming Investor Conferences and Events

InMode Reports First Quarter 2026 Financial Results: Quarterly GAAP Revenue of $82 Million, Represents 5% Year-Over-Year Increase

InMode to Report Q1 2026 Financial Results and Hold Conference Call on May 6, 2026, Expects Q1 Revenue Between $81.5M-$81.7M

Financials & Filings

SEC FILINGS

Contact Us

Contact Us